KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biolife Solutions (BLFS) FCF Margin (2016 - 2025)

Biolife Solutions (BLFS) has disclosed FCF Margin for 16 consecutive years, with 53.96% as the latest value for Q4 2025.

  • On a quarterly basis, FCF Margin rose 4811.0% to 53.96% in Q4 2025 year-over-year; TTM through Dec 2025 was 20.91%, a 1394.0% increase, with the full-year FY2025 number at 20.91%, up 1394.0% from a year prior.
  • FCF Margin was 53.96% for Q4 2025 at Biolife Solutions, up from 3.47% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 53.96% in Q4 2025 to a low of 54.43% in Q2 2023.
  • A 5-year average of 4.38% and a median of 0.97% in 2021 define the central range for FCF Margin.
  • Peak YoY movement for FCF Margin: tumbled -7877bps in 2021, then skyrocketed 8047bps in 2024.
  • Biolife Solutions' FCF Margin stood at 1.79% in 2021, then tumbled by -1127bps to 21.91% in 2022, then tumbled by -96bps to 43.05% in 2023, then surged by 114bps to 5.84% in 2024, then surged by 823bps to 53.96% in 2025.
  • Per Business Quant, the three most recent readings for BLFS's FCF Margin are 53.96% (Q4 2025), 3.47% (Q3 2025), and 29.32% (Q2 2025).